Cost Analysis Of The First Patient-Centered Medical Home (PCMH) in Singapore: Perspectives From Healthcare Providers, Patients, And Society As A Whole
Author(s)
Sum G1, Kadir MM1, Ho SH1, Yoong J2, Tsao MA3, Wong CH4
1Geriatric Education and Research Institute, Singapore, Singapore, 2Center for Economic and Social Research, University of Southern California and Research for Impact, Singapore, Singapore, Singapore, 3Tsao Foundation, Singapore, Singapore, 4Geriatric Education and Research Institute, and Health Services & Systems Research, Duke-NUS, Singapore, Singapore
OBJECTIVES: The first Patient-Centered Medical Home (PCMH) in Singapore was launched in November 2016. Key components encompassed medical care in the primary care clinic and psychosocial care in home-based care management. Our study aimed to examine the cost analysis of this novel model of care from perspectives of healthcare providers, patients and society, and the financing of PCMH services. METHODS: We adopted a micro-costing approach by collecting data on resource use and unit costs of resources. We also considered direct medical and non-medical costs associated with non-PCMH medical facility visits, community care, and informal caregiving by domestic workers and family members. RESULTS: Analysis was conducted on 165 study participants enrolled into PCMH from November’17 to April’20, with mean age 77 years (SD: 9.9). Mean total cost to participants was SGD123(USD93) (13.8%) higher per participant for the first 3-month period post-enrolment and increased by SGD180(USD136) (20.3%) per participant for the subsequent 3-month period, compared to baseline. Total resource cost of PCHM service provision was SGD834(USD628) per participant for the first 3-month period post-enrolment, followed by a significant reduction to SGD407(USD306) per participant for the subsequent 3-month period. There was a concurrent significant decrease in mean costs of other primary care per participant for the first 3- month period post-enrolment and subsequent 3-month period, suggestive of substitution effects due to the intervention. Mean total societal cost increased by SGD560(USD422) (17.8%) per participant for the first 3-month period post-enrolment and increased by SGD365(USD275) (11.6%) per participant for the subsequent 3-month period, compared to baseline. In financing PCMH, government subsidies formed the largest payment component (54% in 1st quarter; 59% in 2nd quarter), followed by PCMH subsidies. Participants paid a minority proportion of the bill. CONCLUSIONS: Evidence from Singapore’s first PCMH demonstration suggests that implementation costs are reasonable, with potential for long-term sustainability.
Conference/Value in Health Info
2021-05, ISPOR 2021, Montreal, Canada
Value in Health, Volume 24, Issue 5, S1 (May 2021)
Code
PMU6
Topic
Economic Evaluation, Epidemiology & Public Health, Patient-Centered Research
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis, Health State Utilities, Public Health
Disease
Multiple Diseases
Explore Related HEOR by Topic